Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
GLOBE HOUSE, LONDON
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
8 Sep 2026

British American Tobacco p.l.c. filed Form 25-NSE

British American Tobacco p.l.c. submitted Form 25-NSE to the SEC.

14 May 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in British American Tobacco p.l.c..

6 May 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in British American Tobacco p.l.c..

25 Mar 2026

British American Tobacco p.l.c. filed Form 25-NSE

British American Tobacco p.l.c. submitted Form 25-NSE to the SEC.

18 Oct 2025

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in British American Tobacco p.l.c..

Capital Structure & Financial Position

Financial strength and liquidity analysis
Verified Capital Structure Unavailable
Balance-sheet, credit-rating, debt, and capital-activity data require sourced financial statement ingestion.

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
Verified Financial Statements Unavailable
Verified financial statement data is not ingested for this stock yet.

Analyst Consensus

Buy
Target: $68.10
15.2% upside potential
📈
Strong Buy
Unavailable
👍
Buy
2
⏸️
Hold
0
📉
Sell
0
2 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 68.10–68.10 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
28
May 2026
BT DE Investments Inc.
Conversion
$0.68 per share
95,281,277 shares
SEC Form 4
28
May 2026
BT DE Investments Inc.
Grant or award
$0.68 per share
14,662,765 shares
SEC Form 4

Top Shareholders

Capital International Investors
49,134,401 shares
0.653% change
6/30/2026
Fmr Llc
44,158,315 shares
20.361% change
6/30/2026
Capital Research Global Investors
30,330,845 shares
-2.041% change
6/30/2026
Gqg Partners Llc
24,566,708 shares
-11.258% change
6/30/2026
Blackrock, Inc.
20,161,366 shares
5.299% change
6/30/2026
Bank Of America Corp /De/
10,534,980 shares
8.197% change
6/30/2026
Capital World Investors
9,737,992 shares
0.513% change
6/30/2026
Morgan Stanley
7,707,052 shares
48.24% change
6/30/2026
Orbis Allan Gray Ltd
7,385,374 shares
-4.16% change
6/30/2026
Jpmorgan Chase & Co
5,390,955 shares
-7.308% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 1 day ago